Elsass Peter, Pedersen Palle, Husum Kristian, Milman Nils
Institute of Psychology, University of Copenhagen, Copenhagen, Denmark.
Ann Hematol. 2008 May;87(5):397-404. doi: 10.1007/s00277-007-0415-2. Epub 2007 Dec 13.
Discovery of genetic variants of the HFE gene has made it possible to screen for hereditary hemochromatosis. However, genetic screening raises ethical, legal, social, and psychological questions, which need to be addressed. To assess the psychological impact on individuals undergoing genetic screening for hereditary hemochromatosis and to determine the effects of providing different levels of information to the participants. Male residents, aged 30-50 years (n = 10,993) were invited to a genetic screening for hereditary hemochromatosis. Carriers of the gene variants H63D, S65C, and C282Y were offered additional biochemical screening using serum ferritin and transferrin saturation. Psychological factors were evaluated through questionnaires before and after genetic and biochemical screening. According to genotype, participants were divided into three groups with different risks profiles for having/developing clinical hemochromatosis (at-risk, uncertain risk, no risk). Before completion of the questionnaires, 929 participants received only genetic information and 366 received both genetic and biochemical information. At-risk participants receiving only genetic information generally displayed negative reactions to the test result, whereas participants receiving both genetic and biochemical information were more satisfied and had fewer negative psychological reactions to the test result. Genetic screening is more readily accepted by subjects when genetic information is supported by biochemical measurements, especially in participants with a risk of clinical disease.
HFE基因遗传变异的发现使得遗传性血色素沉着症的筛查成为可能。然而,基因筛查引发了伦理、法律、社会和心理等方面的问题,这些问题需要得到解决。为了评估遗传性血色素沉着症基因筛查对个体的心理影响,并确定向参与者提供不同程度信息的效果。邀请了年龄在30至50岁之间的男性居民(n = 10993)参加遗传性血色素沉着症的基因筛查。对基因变异H63D、S65C和C282Y的携带者进行了血清铁蛋白和转铁蛋白饱和度的额外生化筛查。在基因和生化筛查前后通过问卷调查对心理因素进行评估。根据基因型,参与者被分为三组,患临床血色素沉着症/发展为临床血色素沉着症的风险不同(高风险、不确定风险、无风险)。在完成问卷之前,929名参与者仅收到基因信息,366名参与者同时收到基因和生化信息。仅收到基因信息的高风险参与者通常对检测结果表现出负面反应,而同时收到基因和生化信息的参与者对检测结果更满意,负面心理反应更少。当基因信息得到生化检测支持时,基因筛查更容易被受试者接受,尤其是在有临床疾病风险的参与者中。